companydata.dkONCONOX ApS: Financial statements 2014
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -49,757 compared with DKK -190,816 the year before. Equity amounted to DKK -93.
- Profit/Loss
- -49,757 kr.
- Equity
- -93 kr.
- Total Assets
- 9,907 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -50 t. | -93 | - |
| 2013 | - | - | -191 t. | 50 t. | - |
| 2012 | - | -705 t. | -712 t. | 240 t. | - |
Keep an eye on ONCONOX ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of ONCONOX ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of ONCONOX ApS.
ONCONOX ApS has published its annual report for 2013. The net result was DKK -190,816.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.